50 Pharmaceutical Companies Raised Medicine Prices by Up to Rs2,000, Says Mustafa Kamal

Federal Health Minister Syed Mustafa Kamal has said that around 50 pharmaceutical companies increased the prices of medicines by as much as Rs2,000.

The minister shared the information during a discussion about medicine pricing and the pharmaceutical sector. The reported increases have raised concerns about the cost of treatment for patients who depend on regular medication.

Medicine Affordability Remains a Concern

Rising medicine costs can place additional pressure on households, particularly those managing long-term conditions that require continuous treatment.

The government regulates prices of medicines included in the National Essential Medicines List, while the pricing framework for medicines outside that list is different.

Government Focuses on Medicine Regulation

The Drug Regulatory Authority of Pakistan (DRAP) oversees medicine pricing and quality standards. The government has also been working on reforms to improve the availability and tracking of medicines.

The minister's remarks have brought renewed attention to the need for effective monitoring of pharmaceutical prices and protection of patients from unexpected increases.

Clear Pricing Information Needed

Patients and healthcare providers need accurate information about approved medicine prices and changes in retail rates.

Further details about the 50 companies, the medicines involved and the individual price adjustments would help clarify the full scale of the reported increases.